Get the Stockscreener App
4.61
4.75%
-0.23
After Hours:
4.70
0.09
+1.95%
Gridai Technologies Corp stock is traded at $4.61, with a volume of 128.92K.
It is down -4.75% in the last 24 hours and up +103.08% over the past month.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
See More
Previous Close:
$4.84
Open:
$4.92
24h Volume:
128.92K
Relative Volume:
1.11
Market Cap:
$28.58M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-1.8897
EPS:
-2.4396
Net Cash Flow:
$-5.70M
1W Performance:
+19.74%
1M Performance:
+103.08%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.50
$5.20
1-Week Range:
$3.78
$5.20
52-Week Range:
$1.87
$5.30
Gridai Technologies Corp Stock (GRDX) Company Profile
Name
Gridai Technologies Corp
Sector
Industry
Phone
561-589-7020
Address
433 PLAZA REAL, BOCA RATON
Compare GRDX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRDX
Gridai Technologies Corp
|
4.61 | 30.01M | 0 | -6.24M | -5.70M | -2.4396 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Gridai Technologies Corp Stock (GRDX) Latest News
Why Is GridAI Technologies Corp. (GRDX) Stock Up Today? - Meyka
GridAI Drops After Debt Agreement as Traders Watch Warrants - Bez Kabli
Why Is GridAI Technologies Corp. (GRDX) Stock Down Today? - Meyka
GridAI Announces Debt Settlement and Equity Conversion Agreement - TipRanks
GridAI Technologies settles $1 million debt with cash payment and stock issuance - Investing.com Australia
GridAI Technologies Resolves Loan Default With $800,000 Payment and 71,482 Shares - TradingView
GridAI Technologies Corp. (NASDAQ: ENTO) resolves loan default with $800,000 cash and 71,482 shares - Stock Titan
GridAI Technologies (GRDX) Stock Analysis: -3.44% Loss — Key Levels 2026-05-19High Reward Trades - Newser
GridAI Technologies Delays Latest Quarterly Filing - TipRanks
GridAI Technologies Corp. (ENTO) delays Q1 2026 10-Q, cites 10-K finalization - Stock Titan
GridAI Technologies Announces New Private Equity Financings - TipRanks
GridAI Technologies Corp enters $2.54 million private placement of shares and warrantsSEC filing - marketscreener.com
Gridai Technologies CorpEnters $2.54 Million Private Placement Of Shares And WarrantsSEC Filing - TradingView
GridAI Technologies Secures $7.79 Million in Private Placements With Warrants - TradingView
GridAI Technologies (NASDAQ: ENTO) details $2.54M and $5.25M private placements with warrants - Stock Titan
TradingKey - TradingKey
What Wall Street expects from GridAI Technologies (GRDX) this quarter | Q3 2024: EPS Misses EstimatesPayout Ratio - newser.com
GRDX | GridAI Technologies Corp. Common Insider Trading - Quiver Quantitative
The fundamentals driving GridAI Technologies (GRDX) everyone should understand (Technical Strength) 2026-05-06Retail Trader Ideas - newser.com
GridAI Regains Nasdaq Compliance After 10-K Filing Delay - TipRanks
GridAI Technologies Corp. (ENTO) back in Nasdaq compliance after delayed 10-K filing - Stock Titan
GridAI Technologies misses 10-K filing deadline; Nasdaq issues warning - MSN
The organic vs inorganic growth story at GridAI Technologies (GRDX) - newser.com
GridAI Technologies Corp. (GRDX): AI Data Center Energy Optimization, Legacy Biopharma, and Corporate Transformation – 2025 Annual Report Highlights - Minichart
GridAI Technologies Corp. — FY Results: Revenue, Net income, EPS Not Disclosed — 10-K Summary - TradingView
GridAI Technologies (Nasdaq: GRDX) pivots to AI energy while warning on going concern - Stock Titan
GridAI Technologies to Showcase AI-Powered Energy Platform at Market Movers Investor Summit - MEXC Exchange
GridAI Technologies Corp. to Present at the Market Movers Investor Summit - The Globe and Mail
PRN_FinancialWrapper - FinancialContent
GridAI Technologies Receives Nasdaq Notice for Late 10-K Filing Following Grid AI Corp. Acquisition - Minichart
GridAI Technologies Faces Nasdaq Noncompliance Over Delayed 10-K - TipRanks
GridAI Technologies Corp. - TMX Newsfile
GridAI Technologies Received Notice of Noncompliance - TradingView
GridAI Technologies (NASDAQ: GRDX) flagged by Nasdaq for late 2025 10-K - Stock Titan
GridAI has until June 22 to submit Nasdaq plan over late annual report - Stock Titan
GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing - The Globe and Mail
Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. - MSN
GRDX (GridAI Technologies) posts wider than expected Q3 2024 per share loss, stock falls 1.09% in today’s session.Return On Capital - Newser
GridAI Technologies Faces Default on Revolving Loan Agreement - TipRanks
Gridai Technologies Corp Stock (GRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):